eversyn GmbH

eversyn is a Max Planck spin-off that leverages cutting-edge biotechnology to make vital glycan molecules accessible at both R&D and industrial scales. They provide affordable activated sugars and enzymes for protein glycosylation and glycan engineering, aiming to unlock the full potential of glycans for innovations in nutrition and biopharma.